Vertex Pharmaceuticals Incorporated shares owned by Virtus ETF Advisers
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Virtus ETF Advisers
from 13F filings
Historical chart of Virtus ETF Advisers investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Virtus ETF Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.2M | 2.5k | 465.08 |
2024-06-30 | $1.3M | 2.8k | 468.72 |
2024-03-31 | $1.1M | 2.7k | 418.01 |
2023-12-31 | $974k | 2.4k | 406.89 |
2023-09-30 | $1.0M | 3.0k | 347.74 |
2023-06-30 | $1.2M | 3.4k | 351.91 |
2023-03-31 | $1.2M | 3.8k | 315.07 |
2022-12-31 | $1.0M | 3.5k | 288.78 |
2022-09-30 | $969k | 3.3k | 289.60 |
2022-06-30 | $1.0M | 3.6k | 282.19 |
2022-03-31 | $464k | 1.8k | 260.97 |
2021-12-31 | $390k | 1.8k | 219.35 |
2021-09-30 | $426k | 2.4k | 181.28 |
2021-06-30 | $517k | 2.6k | 201.72 |
2021-03-31 | $589k | 2.7k | 215.04 |
2020-12-31 | $631k | 2.7k | 236.51 |
2020-09-30 | $592k | 2.2k | 272.06 |
2020-06-30 | $633k | 2.2k | 290.50 |
2020-03-31 | $638k | 2.7k | 237.97 |
2019-12-31 | $637k | 2.9k | 219.05 |
2019-09-30 | $689k | 4.1k | 169.37 |
2019-06-30 | $872k | 4.8k | 183.35 |
2019-03-31 | $814k | 4.4k | 183.87 |
2018-12-31 | $586k | 3.5k | 165.77 |
2018-09-30 | $974k | 5.1k | 192.83 |
2018-06-30 | $801k | 4.7k | 170.03 |
2018-03-31 | $1.0M | 6.3k | 162.93 |
2017-12-31 | $1.0M | 6.8k | 149.90 |
2017-09-30 | $1.3M | 8.3k | 152.05 |
2017-06-30 | $1.1M | 8.3k | 128.92 |
2017-03-31 | $1.4M | 13k | 109.32 |
2016-12-31 | $880k | 12k | 73.66 |
2016-09-30 | $594k | 6.8k | 87.17 |
2016-06-30 | $512k | 6.0k | 85.98 |
2016-03-31 | $400k | 5.0k | 79.48 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated